Keywords: sciele, pharma, reaffirms, guidance, drugmaker, says, including

Sciele Pharma reaffirms 2007 guidance

Article | 21 January 2008

Print This

US drugmaker Sciele Pharma says that, including the impact of a $0.10 per share charge, its 2007 revenue will be in the $375 ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in